Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharma Tech Industries Appoints Interim CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Pharma Tech Industries Appoints Interim CEO

VanVliet joins the company with more than 20 years of experience serving in executive roles

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

David VanVliet has been appointed interim chief executive officer, Pharma Tech Industries. Mr. VanVliet will assume overall leadership of the company, while industry veteran Tee Noland will transition to a new role as Pharma Tech’s chairman of the board.

Mr. VanVliet joins the company with more than 20 years of experience serving in executive roles spanning the healthcare and pharmaceutical sectors.

Most recently, he served as president and chief executive officer of Angelica, Inc., a supplier to thousands of hospitals, clinics and long-term care facilities. Mr. VanVliet successfully guided the company’s 4,000 employees and 26 production centers. He also has held leadership roles at companies including KV Pharmaceutical, Procter & Gamble, and Nabisco, Inc.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters